查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609615

帕金森氏症的深部腦刺激市場規模、佔有率和趨勢分析報告：按產品、最終用途、按地區、細分市場預測，2025-2030 年

Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product (Single-channel, Dual-channel), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

深部腦部刺激市場的成長和帕金森氏症的趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，帕金森氏症腦深部刺激的全球市場規模預計將達到16.1億美元，2025年至2030年的複合年成長率為10.1%。

帕金森氏症 (PD) 盛行率的快速上升以及人們對帕金森氏症深部腦部刺激的認知不斷增強，正在推動市場的發展。

帕金森氏症患者病率的上升推動了對深部腦部刺激作為替代療法的需求。深部腦部刺激已被證明在為帕金森氏症症狀提供治療解決方案方面發揮關鍵作用，預計將在預測期內推動市場成長。

此外，由於患者預後改善，對微創治療的需求不斷成長，也是該市場的影響因素。這是因為其成本效益高、痛苦小、安全、住院時間短、恢復快、術後問題少。預計這些主要因素將在預測期內推動對深層腦部刺激器的需求。

此外，主要企業旨在改善術後結果和減少治療帕金森氏症症狀的副作用的技術進步預計也將推動對深部腦部刺激的需求。例如，2020年1月，雅培的Infinity深部腦部刺激系統獲得FDA核准，擴大PD治療適應症。該系統允許患者針對大腦中稱為蒼白球內部（GPi）的特定區域進行治療，該區域與帕金森氏症症狀相關。

帕金森氏症市場報告的深部腦部刺激亮點

  • 雙通道在減少患者震顫方面非常有效，因此擴大被神經外科醫生採用，到 2024 年將佔據市場 56.9% 的佔有率。
  • 從最終用途來看，醫院將在 2024 年佔據市場主導地位，因為深部腦部刺激是最複雜、最重要的手術，並且由於擁有高品質和耐用的設備而在醫院進行。
  • 由於精神障礙盛行且該地區擁有完善的醫療設施，北美將在 2024 年佔據市場主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章帕金森氏症市場的深部腦部刺激的變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章帕金森氏症市場的深部腦部刺激：產品展望、估計與預測

  • 帕金森氏症的深部腦部刺激市場：2024 年和 2030 年產品變化分析
    • 單通道
    • 雙通道

第5章帕金森氏症市場的深部腦部刺激：最終用途展望、估計與預測

  • 帕金森氏症的深部腦部刺激市場：2024 年和 2030 年最終用途變化分析
    • 醫院
    • 神經科門診
    • 門診手術中心
    • 研究中心

第6章帕金森氏症市場的深部腦部刺激：區域展望、估計與預測

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 德國
    • 英國
    • 義大利
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 中國
    • 日本
    • 印度
    • 印尼
    • 韓國
    • 泰國
    • 澳洲
    • 菲律賓
    • 馬來西亞
    • 新加坡
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 委內瑞拉
  • 中東/非洲
    • 2018-2030 年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 土耳其
    • 伊朗
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 供應商情況
    • 公司分類
    • 主要經銷商及通路夥伴名單
    • 潛在客戶/最終用戶列表
  • 競爭動態
    • 競爭標基準化分析
    • 策略規劃
    • 熱圖分析
  • 公司簡介/名單
    • ABBOTT
    • Medtronic
    • Boston Scientific Corporation
Product Code: GVR-4-68038-749-0

Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The global deep brain stimulation in Parkinson's disease market size is anticipated to reach USD 1.61 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.1% from 2025 to 2030. Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy. Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.

Moreover, increasing demand for minimally invasive therapies due to improved patient outcomes is a high impact rendering driver for this market. This is due to high cost efficiency, minimal pain, safety, short duration of hospital stays, speedy recovery, and few cases of post-surgical problems. These key factors are anticipated to raise the demand for deep brain stimulators over the forecast period.

In addition, technological advancements by the key players for the improved postoperative outcomes and reduced adverse effects in the treatment of PD symptoms are anticipated to raise the demand for deep brain stimulation. For instance, in January 2020, Abbott's Infinity deep brain stimulation system has secured expanded indication approval from the FDA for the treatment of PD. This system will allow to target patients' specific area of the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms.

Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

  • The dual channel segment dominated the market with the share of 56.9% in 2024 owing to its increasing adoption by neurosurgeons as it is highly effective in reducing patient tremors
  • On the basis of end-use, hospitals dominated the market in 2024 since deep brain stimulation procedures are the most complicated and critical surgeries that are performed in hospitals due to availability of high quality and durable equipment
  • North America dominated the market with in 2024 owing to prevalence of psychological disorders and presence of well-established healthcare facilities in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Deep Brain Stimulation In Parkinson's Disease Market: Product Outlook Estimates & Forecasts

  • 4.1. Deep Brain Stimulation In Parkinson's Disease Market: Product Movement Analysis, 2024 & 2030
    • 4.1.1. Single-channel
      • 4.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.2. Dual-channel
      • 4.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Deep Brain Stimulation In Parkinson's Disease Market: End Use Outlook Estimates & Forecasts

  • 5.1. Deep Brain Stimulation In Parkinson's Disease Market: End Use Movement Analysis, 2024 & 2030
    • 5.1.1. Hospitals
      • 5.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.2. Neurology Clinics
      • 5.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.3. Ambulatory Surgical Centers
      • 5.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.4. Research Centers
      • 5.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Deep Brain Stimulation In Parkinson's Disease Market Regional Outlook Estimates & Forecasts

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive insights
      • 6.4.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive insights
      • 6.4.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive insights
      • 6.4.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive insights
      • 6.5.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. UK
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive insights
      • 6.5.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive insights
      • 6.5.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive insights
      • 6.5.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive insights
      • 6.5.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Spain
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive insights
      • 6.5.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive insights
      • 6.5.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive insights
      • 6.5.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Norway
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework
      • 6.5.10.3. Competitive insights
      • 6.5.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive insights
      • 6.6.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Japan
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive insights
      • 6.6.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive insights
      • 6.6.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Indonesia
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive insights
      • 6.6.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive insights
      • 6.6.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive insights
      • 6.6.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Australia
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive insights
      • 6.6.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.9. Philippines
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework
      • 6.6.9.3. Competitive insights
      • 6.6.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.10. Malaysia
      • 6.6.10.1. Key country dynamics
      • 6.6.10.2. Regulatory framework
      • 6.6.10.3. Competitive insights
      • 6.6.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.11. Singapore
      • 6.6.11.1. Key country dynamics
      • 6.6.11.2. Regulatory framework
      • 6.6.11.3. Competitive insights
      • 6.6.11.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive insights
      • 6.7.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive insights
      • 6.7.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. Colombia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive insights
      • 6.7.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Chile
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive insights
      • 6.7.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Venezuela
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive insights
      • 6.7.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive insights
      • 6.8.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive insights
      • 6.8.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive insights
      • 6.8.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Turkey
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive insights
      • 6.8.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.6. Iran
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Regulatory framework
      • 6.8.6.3. Competitive insights
      • 6.8.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.7. Kuwait
      • 6.8.7.1. Key country dynamics
      • 6.8.7.2. Regulatory framework
      • 6.8.7.3. Competitive insights
      • 6.8.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Vendor Landscape
    • 7.2.1. Company categorization
    • 7.2.2. List of Key Distributors and Channel Partners
    • 7.2.3. List of Potential Customers/End Users
  • 7.3. Competitive Dynamics
    • 7.3.1. Competitive Benchmarking
    • 7.3.2. Strategy Mapping
    • 7.3.3. Heat Map Analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. ABBOTT
      • 7.4.1.1. Participant's overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Medtronic
      • 7.4.2.1. Participant's overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Boston Scientific Corporation
      • 7.4.3.1. Participant's overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
  • Table 3. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 4. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by region, 2018 - 2030 (USD Million)
  • Table 5. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 6. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 7. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 8. U.S. deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 9. U.S. deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 11. Canada deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 12. Mexico deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 13. Mexico deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 16. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 17. UK deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 18. UK deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Germany deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 20. Germany deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 21. France deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 22. France deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23. Italy deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 24. Italy deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Spain deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 26. Spain deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 27. Denmark deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 28. Denmark deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 29. Sweden deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 30. Sweden deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Norway deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 32. Norway deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 36. Japan deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 37. Japan deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 38. China deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 39. China deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 40. India deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 41. India deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 42. Indonesia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 43. Indonesia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 44. South Korea deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 45. South Korea deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 46. Thailand deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 47. Thailand deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 48. Australia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 49. Australia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 50. Philippines deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 51. Philippines deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Malaysia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 53. Malaysia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 54. Singapore deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 55. Singapore deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 56. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 57. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 58. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 59. Brazil deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 60. Brazil deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Argentina deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 62. Argentina deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63. Colombia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 64. Colombia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Chile deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 66. Chile deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 67. Venezuela deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 68. Venezuela deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 70. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 71. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 72. South Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 73. South Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 74. Saudi Arabia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75. Saudi Arabia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 76. UAE deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 77. UAE deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 78. Turkey deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79. Turkey deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 80. Iran deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 81. Iran deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 82. Kuwait deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 83. Kuwait deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Market snapshot
  • Fig. 6 Segmental outlook- Product, and End Use
  • Fig. 7 Competitive outlook
  • Fig. 8 Value chain analysis
  • Fig. 9 Market dynamics
  • Fig. 10 Porter's analysis
  • Fig. 11 PESTEL analysis
  • Fig. 12 Deep brain stimulation In Parkinson's disease market, by product: Key takeaways
  • Fig. 13 Deep brain stimulation In Parkinson's disease market, by product: Market share, 2024 & 2030
  • Fig. 14 Deep brain stimulation In Parkinson's disease market, by end use: Key takeaways
  • Fig. 15 Deep brain stimulation In Parkinson's disease market, by end use: Market share, 2024 & 2030
  • Fig. 16 Deep brain stimulation In Parkinson's disease market, by region: Key takeaways
  • Fig. 17 Deep brain stimulation In Parkinson's disease market, by region: Market share, 2024 & 2030